Skip to content
My WebMD Sign In, Sign Up
Latest In Pathology & Lab Medicine
Filter
All U.S. Non-U.S.

Select all that apply

Topics

    Credits

      Format

        Type

          0 global 1 1.00 9 1.00 2 1.00 3 1.00 Hematology-Oncology CME / ABIM MOC / CE 1.0 Roundtable 0 1
          Explore the latest breakthroughs and strategies shaping the future of immunotherapy in advanced non-small cell lung cancer (NSCLC). Start activity
          Immunotherapy in Advanced Non-Small Cell Lung Cancer
          View Details
          0 global 1 1.25 9 1.25 2 1.25 3 1.25 Hematology-Oncology CME / ABIM MOC / CE 1.25 Roundtable 0 1
          Take a deep dive into the latest innovations and best practices shaping the future of treatment in early-stage and locally advanced non-small cell lung cancer (NSCLC). Start activity
          Early-Stage and Locally Advanced Non-Small Cell Lung Cancer Management
          View Details
          Ovarian Cancer 839 global 1 0.50 9 0.50 2 0.50 3 0.50 Hematology-Oncology CME / ABIM MOC / CE 0.5 Roundtable 0 1
          Do you know the best way to manage your patients with newly diagnosed advanced ovarian cancer? Start activity
          Evolution of the Care of Patients With Advanced Ovarian Cancer
          View Details
          Colorectal Cancer 3032296 global 1 1.0 9 1.0 Hematology-Oncology CME / ABIM MOC 1.0 Clinical Case 0 1
          Do you know how to best use tyrosine kinase inhibitors (TKIs) in your patients with metastatic colorectal cancer (CRC)? Start activity
          Optimizing Sequencing of Oral Tyrosine Kinase Inhibitors in Metastatic Colorectal Cancer
          View Details
          Breast Cancer 840 global 1 0.5 9 0.5 2 0.5 3 0.5 8 0.5 Hematology-Oncology CME / ABIM MOC / CE 0.5 Clinical Review 0 2
          Hear from a breast cancer survivor about her experience with positive and negative words and actions by those around her. Start activity
          Defining Moments: Empowering Patients With Breast Cancer and Survivors in Their Journey
          View Details
          0 global 1 0.50 9 0.50 2 0.50 Hematology-Oncology CME / ABIM MOC / CE 0.5 Roundtable 0 1
          How do you define high-risk for recurrence in breast cancer? Start activity
          Community Collaboration: Application of CDK 4/6 Inhibitors in the Treatment of HR-Positive/HER2-Negative Early Breast Cancer
          View Details
          Curated Collections
          Curated activities and resources from our partners and committee
          You Might Like
          Because you completed the activity:
          Upcoming Events
          Simulation
           
          URAC: Accredited Health Web Site HonCode: Health on the Net Foundation AdChoices